O-(β-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: An independent prospective comparative study

Angiology

Volumn 59, Issue 1, 2008, Pages

  Belcaro, Gianni ^a   Rosaria Cesarone, Maria ^a   Ledda, Andrea ^a   Cacchio, Marisa ^a   Ruffini, Irma ^a   Ricci, Andrea ^a   Ippolito, Edmondo ^a   Di Renzo, Andrea ^a   Dugall, Mark ^a   Corsi, Marcello ^a   Marino Santarelli, Anna Rita ^a   Grossi, Maria Giovanna ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Edema; Elastic compression; HR; O ( hydroxyethyl) rutosides; Ulcerations; Varicose veins; Veins; Venous disease; Venous microangiopathy

Indexed keywords

CARBON DIOXIDE; MONOXERUTIN; OXYGEN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CARBON DIOXIDE TENSION; CHRONIC VEIN INSUFFICIENCY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPRESSION GARMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; HUMAN; LASER DOPPLER FLOWMETRY; MALE; MICROANGIOPATHY; MICROCIRCULATION; OXYGEN TENSION; PROSPECTIVE STUDY; SKIN TEST; STATISTICAL SIGNIFICANCE; VEIN DISEASE; VENOUS PRESSURE; COMPRESSION STOCKING; DOPPLER FLOWMETRY; DRUG DOSAGE FORM COMPARISON; MAJOR CLINICAL STUDY; TRANSCUTANEOUS CARBON DIOXIDE MONITORING; TRANSCUTANEOUS OXYGEN MONITORING; VENOUS REFLUX;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; BLOOD FLOW VELOCITY; BLOOD GAS MONITORING, TRANSCUTANEOUS; CAPILLARY PERMEABILITY; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; DIABETIC ANGIOPATHIES; EDEMA; GELS; HUMANS; HYDROXYETHYLRUTOSIDE; LASER-DOPPLER FLOWMETRY; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; SEVERITY OF ILLNESS INDEX; SKIN; STOCKINGS, COMPRESSION; TIME FACTORS; TREATMENT OUTCOME; VENOUS INSUFFICIENCY; VENOUS PRESSURE;

EID: 39149125409     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707312021     Document Type: Article

References (45)

1. Beckers C., Zijilstra JA New aspects of the pathogenesis of CVI and the site of action of VenorutonR. Phlebology Digest. 2001 ; 14: 8-11.
2. Belcaro G., Rulo A., Candiani C. Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension with laser Doppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements. Vasa. 1989 ; 18 (2). 146-151.
3. Cesarone MR, Ricci A., Belcaro G., et al. Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose-comparison study). Vasa. 1992 ; 21 (1). 76-79.
4. Belcaro G., D'Aulerio A., Rulo A., Candiani C. Evaluation of capillary permeability and microcirculation in patients with chronic venous hypertension treated with Venoruton by the vacuum suction chamber (VSC) device and laser-Doppler flowmetry. Phlebologie. 1998 ; 41 (4). 847-856.
5. Incandela L., Belcaro G., Renton S., et al. HR (Paroven, Venoruton; O-[β-hydroxyethyl]-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial J Cardiovasc Pharmacol Ther. 2002 ; 7 (suppl 1). S7 - S10.
6. Incandela L., Cesarone MR, DeSanctis MT, Belcaro G., Dugall M., Acerbi G. Treatment of diabetic microangiopathy and edema with HR (Paroven, Venoruton; O-[β-hydroxyethyl]-rutosides): a prospective, placebo-controlled, randomized study. J Cardiovasc Pharmacol Ther. 2002 ; 7 (suppl 1). S11 - S15.
7. Cesarone MR, Belcaro G., Geroulakos G., et al. Flight microangiopathy in medium-to-long-distance flights: prevention of edema and microcirculation alterations with HR (Paroven, Venoruton; O-[β-hydroxyethyl]-rutosides) J Cardiovasc Pharmacol Ther. 2002 ; 7 (suppl 1). S17 - S19.
8. Cesarone MR, Incandela L., DeSanctis MT, Belcaro G., Griffin M., Ippolito E. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; O-[β-hydroxyethyl]-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. J Cardiovasc Pharmacol Ther. 2002 ; 7 (suppl 1). S21 - S25.
9. Cesarone MR, Incandela L., DeSanctis MT, Belcaro G., Dugall M., Acerbi G. Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; O-[β-hydroxyethyl]-rutosides): a clinical, prospective, placebo-controlled, randomized trial. J Cardiovasc Pharmacol Ther. 2002 ; 7 (suppl 1). S25 - S28.
10. Belcaro G, Nicolaides AN, Stansby G, eds. The Venous Clinic. London, England: Imperial College Press ; 1999.
11. DeSanctis MT, Cesarone MR, Incandela L., Belcaro G., Acerbi G. Methods of evaluation and quantification of microangiopathy in high perfusion microangiopathy (chronic venous insufficiency and diabetic microangiopathy). J Cardiovasc Pharmacol Ther. 2002 ; 7 (suppl 1). S3 - S5.
12. Belcaro G, Nicolaides AN, eds. Noninvasive Investigations in Vascular Disease. London, England: Imperial College Press ; 2001.
13. Almond NE A laser Doppler blood flowmeter used to detect thermal entrainment in normal persons and patients with Raynaud's phenomenon. In: Spence VA, Sheldon CD, eds. Practical Aspects of Skin Blood Flow Measurement. London, England: Biological Engineering Society; 1985.
14. Anning ST The cause and treatment of leg ulcers. Lancet. 1952 ; 2 (17). 789-791.
15. Anning ST Leg Ulcers: Their Causes and Treatment. London, England: J & A Churchill Ltd; 1954.
16. Anning ST The historical aspect. In: Dodd H, Cockett FB, eds. The Pathology and Surgery of the Veins of the Lower Limb. Edinburgh, Scotland: Churchill-Livingstone; 1976.
17. Belcaro G. The role of transcutaneous PCO2 measurements in association with laser Doppler flowmetry in venous hypertension. Phlebology. 1988 ; 3: 189-193.
18. Belcaro G., Grigg M., Rulo A., Nicolaides AN Blood flow in the perimalleolar skin in relation to posture in patients with venous hypertension. Ann Vasc Surg. 1989 ; 3 (1). 5-8.
19. Belcaro G., Christopoulos D., Nicolaides AN Skin flow and swelling in postphlebitic limbs. Vasa. 1989 ; 18 (2). 136-138.
20. Belcaro G., Nicolaides AN, Volteas N., Leon M. Skin flow, the venoarteriolar response and capillary filtration in diabetics: a three-year follow-up study. Angiology. 1992 ; 43 (6). 490-494.
21. Belcaro G, Bollinger A, Hoffman U, Nicolaides AN, eds. Laser Doppler Flowmetry. London, England: Med-Orion ; 1994.
22. Bergan JJ, Schmid-Schönbein GW, Takase S. Therapeutic approach to chronic venous insufficiency and its complications: place of Daflon 500 mg. Angiology. 2001 ; 52 (suppl 1). S43 - S47.
23. Bollinger A., Jäger K., Geser A., Sgier F., Seglias J. Trans-capillary and interstitial diffusion of Na-fluorescein in chronic venous insufficiency with white atrophy. Int J Microcirc Clin Exp. 1982 ; 1 (1). 5-17.
24. Fagrell B. Local microcirculation in chronic venous incompetence and leg ulcers Vasc Surg. 1979 ; 13: 217-219.
25. Fagrell B. Microcirculatory disturbances: the final cause for venous leg ulcers? Vasa. 1982 ; 11 (2). 101-103.
26. Fagrell B. Problems using laser Doppler flowmetry on the skin in clinical practice In: Belcaro G, Hoffman U, Nicolaides AN, Bollinger A, eds. Laser Doppler London, England: Med-Orion ; 1994 ; 49-53.
27. Franzeck U., Bollinger A., Huch R., Huch A. Transcutaneous oxygen tension and capillary morphologic characteristics and density in patients with chronic venous incompetence. Circulation. 1984 ; 70 (5). 806-809.
28. Henriksen O. Local reflex in microcirculation in human subcutaneous tissue Acta Physiol Scand. 1976 ; 97 (4). 446-449.
29. Rayman G., Hassan A., Tooke JE Blood flow in the skin of the foot related to posture in patients with diabetes mellitus. Br Med J (Clin Res Ed). 1986 ; 292 (6513). 87-90.
30. Thulesius O. Capillary filtration under normal and pathological conditions. Angiologia. 1973 ; 10: 198-201.
31. Poynard T., Valterio C. Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency. Vasa. 1994 ; 23 (3). 244-250.
32. Ekestrom S., Welti R. The affinity of hydroxyethyl-rutosides for the venous wall and its efficacy in preventing early occlusion of aorto-coronary vein bypass grafts Phlebology. 1990 ; 5 (suppl 1). 41-48.
33. Nees S., Juchem G., Fink R., Abbogast A. Influence of polymorphonuclear leukocytes and platelets on the barrier function of cultured venular endothelial cells. In: Proceedings of the Sixth World Congress on Microcirculation Bologna, Italy: Monduzzi; 1996 :401-404.
34. Roland IH, Bougelet C., Ninane N., Arnaud T., Michiels C., Remacle J. Effect of hydroxyethylrutosides on hypoxial-induced neutrophil adherence to umbilical vein endothelium. Cardiovasc Drugs Ther. 1998 ; 12 (4). 375-381.
35. Liu F., Xu Y., Rui L., Gao S., Dong H., Guo Q. Liquid chromatography/tandem mass spectrometry assay for the quantification of troxerutin in human plasma. Rapid Commun Mass Spectrom. 2006 ; 20 (23). 3522-3526.
36. Yang X., Wang F., Hu S. The electrochemical oxidation of troxerutin and its sensitive determination in pharmaceutical dosage forms at PVP modified carbon paste electrode. Colloids Surf B Biointerfaces. 2006 ; 52 (1). 8-13.
37. Cesarone MR, Belcaro G., Pellegrini L., et al. Circulating endothelial cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with Venoruton. J Cardiovasc Pharmacol Ther. 2006 ; 11 (1). 93-98.
38. Gutierrez RM, Solis RV, Baez EG, Martinez FM Effect on capillary permeability in rabbits of iridoids from Buddleia scordioides. Phytother Res. 2006 ; 20 (7). 542-545.
39. Cesarone MR, Belcaro G., Pellegrini L., et al. Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency. Angiology. 2006 ; 57 (2). 131-138.
40. Furfaro AL, Menini S., Patriarca S., et al. HNE-dependent molecular damage in diabetic nephropathy and its possible prevention by N-acetyl-cysteine and oxerutin. Biofactors. 2005 ; 24 (1-4). 291-298.
41. Maurya DK, Balakrishnan S., Salvi VP, Nair CK Protection of cellular DNA from ©-radiation-induced damages and enhancement in DNA repair by troxerutin. Mol Cell Biochem. 2005 ; 280 (1-2). 57-68.
42. Chung HK, Choi SM, Ahn BO, Kwak HH, Kim JH, Kim WB Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy. Arzneimittelforschung. 2005 ; 55 (10). 573-580.
43. Cesarone MR, Belcaro G., Ricci A., et al. Prevention of edema and flight microangiopathy with Venoruton (HR), (O-[β-hydroxyethyl]-rutosides) in patients with varicose veins. Angiology. 2005 ; 56 (3). 289-293.
44. Cesarone MR, Belcaro G., Pellegrini L., et al. HR, O-(βhydroxyethyl) -rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study. Angiology. 2005 ; 56 (2). 165-172.
45. Adam BS, Pentz R., Siegers CP, Strubelt O., Tegtmeier M. Troxerutin protects the isolated perfused rat liver from a possible lipid peroxidation by coumarin. Phytomedicine. 2005 ; 12 (1-2). 52-61.